Evan Melrose - Profile and Investment Details

Investor Profile

Evan Melrose is a Venture Capital, Private Equity Firm based in Austin, Texas, United States with a diverse investment portfolio that includes companies such as BioSET (acquired by Ferring Pharmaceuticals), HNI Healthcare, Ziopharm Oncology (Nasdaq: ZIOP)Burrill & Company, Edgemont Pharmaceuticals acquired by Alvogen (CVC Capital), Qspex Technologies, Bioventus (Nasdaq: BVS), Alexza Pharmaceuticals (Nasdaq: ALXA acquired by Ferrer), IDEV Technologies (acquired by Abbott NYSE: ABT), AMERICAN ACADEMY OF FAMILY PHYSICIANS-VIRGINIA ACADEMY, Biomimetic Therapeutics (Nasdaq: BMTI), Accumetrics acquired by Accriva Diagnostics (Warburg Pincus), BioForm Medical (Nasdaq: BFRM-acquired by MERZ), PANTERRA CAPITAL PARTNERS, a healthcare IT and medical device venture firm, LDR (Nasdaq: LDRH), Spindletop Capital, Insite Vision (Ticker: ISV acquired SUN Pharma), Cameron Health (acquired by Boston Scientific: BSCI), GlycoMimetics (Nasdaq: GLYC), . Over time, Evan Melrose has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Evan Melrose is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Hospitals, Wellness, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Finance, Medical Devices, Health Diagnostics, Medical, B2B, Healthcare Technology may find it worthwhile to explore potential connections with Evan Melrose, as their portfolio suggests a familiarity and interest in this area.

Understanding Evan Melrose’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.